Infectious Disease Clinics of North America volume 20, issue 1, P1-25 2006 DOI: 10.1016/j.idc.2006.01.003 View full text
|
|
Share
Paul H. Hayashi, Adrian M. Di Bisceglie

Abstract: Much information has been gained in the diagnosis and treatment of HCC during the last 15 years. Ever improving imaging technology has made nonhistologic diagnostic criteria possible, albeit controversial. Liver transplantation, resection, and RFA are considered curative options. Yet,HCC incidence is steadily rising because of limited progress on disease prevention. Accurate and cost-effective screening is necessary. Presently, only 10% to 15% of HCC patients present with a curative stage of disease. Because t…

expand abstract